濮阳东方医院男科割包皮手术很靠谱-【濮阳东方医院】,濮阳东方医院,濮阳东方看男科评价非常好,濮阳东方医院男科治早泄口碑很好放心,濮阳东方男科医院割包皮收费比较低,濮阳东方看男科病好吗,濮阳东方医院男科治早泄比较好,濮阳东方医院男科治疗早泄评价好很专业
濮阳东方医院男科割包皮手术很靠谱濮阳东方看病好不好,濮阳东方医院妇科线上挂号,濮阳东方医院割包皮口碑好不好,濮阳东方上班时间,濮阳东方医院治疗阳痿价格合理,濮阳市东方医院好挂号吗,濮阳东方看男科病怎么样
BEIJING, May 30 (Xinhuanet) -- Chronic diseases, including heart disease, stroke, cancer, chronic respiratory diseases and diabetes, are the leading cause of mortality in China, representing 85 percent of all deaths, said a senior health official.Kong Lingzhi, deputy director of the disease prevention and control bureau under the Ministry of Health, made the remarks on Saturday at the Forum of Prevention and Control of Chronic Disease."China is facing a great challenge from chronic diseases, which has a serious impact on both the economy and society," said Kong.Each year, about 3.7 million people die before they reach 60 because of chronic diseases. There are currently 200 million hypertension patients and 90 million diabetics in China, official statistics show.To address the challenge, "the government is now drafting an inter-ministerial roadmap for chronic disease intervention, which will set targets, define responsibilities and distribute guidelines for the prevention and control of chronic diseases," she said.The initiative aims to strengthen national and global monitoring and surveillance; scale up the implementation of evidence-based measures to reduce risk factors, such as tobacco use, an unhealthy diet, physical inactivity and harmful alcohol use; and improve access to cost-effective healthcare to prevent complications, disabilities and premature death.But more importantly, the roadmap will help gain attention and support for preventing and controlling chronic diseases and place it high on government working agendas, Kong explained.The government has focused more on addressing instant health crises up to now and policy and funding support for chronic disease control and prevention was very limited, admitted Mao Qun'an, spokesman of the ministry.Given that chronic disease control requires a systematic approach, tasks such as public health education, training for medical workers (especially the grassroots ones) and policies encouraging doctors' involvement need to be carried out, he said.The ultimate goal is to prevent people from getting ill rather than treating diseases, he added.Lei Zhenglong, deputy director of the disease prevention and control bureau, said that to enhance the capacity of medical workers was now the top priority for the initiative.At present, effective disease prevention work usually contradicts the financial interests of clinical doctors, analysts said.A respiratory disease doctor surnamed He with the Peking University People's Hospital said that he came under pressure from the hospital authorities when the number of inpatients declined due to his efforts to inform his patients about chronic disease prevention.
SAN FRANCISCO, Aug. 3 (Xinhua)-- Google's top legal officer on Wednesday posted a scathing blog post, accusing Microsoft, Apple, Oracle and other companies of waging "bogus" patent wars over smartphone technologies.More than 550,000 Android devices are activated daily, but the success of the mobile operating system has yielded "a hostile, organized campaign against Android by Microsoft, Oracle, Apple and other companies, waged through bogus patent," said Google Senior Vice President and Chief Legal Officer David Drummond."Microsoft and Apple have always been at each other's throats, so when they get into bed together you have to start wondering what's going on," wrote Drummond at the beginning of the blog post under the heading "When patents attack Android."The top legal officer lashed out the coalition that Apple and Microsoft formed to buy Novell patents and Nortel patents.Last month, Google was outbid by the 4.5 billion bid made by the winning consortium of companies that includes Apple, Microsoft, Research in Motion, Sony, Ericsson and EMC on Canadian company Nortel Network's patent portfolio.The Nortel portfolio, which is in all of the companies'best legal interests, includes patents on 3G and 4G wireless networking, optics, voice processing, semiconductors and more.Last December, an unnamed consortium of companies, organized by Microsoft and including Apple, EMC and Oracle, also outbid Google for nearly 900 patents of software company Novell.Patent litigation between technology companies have been flaring up particularly over mobile devices and technology.Last August, Oracle accused Google of infringing on patents related to Java, which the database giant acquired when it took ownership of Sun Microsystems in early 2010.Microsoft is suing device makers who use Android, including Barnes & Noble, Motorola and HTC.Drummond wrote that "We're also looking at other ways to reduce the anti-competitive threats against Android by strengthening our own patent portfolio. Unless we act, consumers could face rising costs for Android devices -- and fewer choices for their next phone."
BEIJING, July 26 (Xinhuanet) -- Seven of the 20 top selling American prescription drugs will lose their patents by the end of next year, making way for less expensive generic versions, according to media reports.It's a shift that could save consumers billions of dollars -- assuming those big-ticket medications are willing to give up a trusted brand name for an off-label replacement.The prices of medications such as cholesterol-fighting Lipitor and blood thinner Plavix are expected to go down significantly, according to the U.S. Food and Drug Administration (FDA).Lipitor will lose its patent in November. When that patent expires, people are advised to buy atorvastatin, the generic equivalent. Other brand names include the anti-psychotic Zyprexa and the rheumatoid arthritis and psoriasis drug Enbrel, of which the patent will expire in October and October of next year, respectively.Over the next 10 years, an estimated 120 more brand-name prescription drugs will lose their patents in the U.S.
WASHINGTON, Aug. 12 (Xinhua) -- NASA announced Friday the creation of a new directorate that will focus on both the International Space Station operations and human exploration beyond low earth orbit.The Human Exploration and Operations Mission Directorate combines the Space Operations and Exploration Systems mission directorates. While the transition and personnel assignments will take several weeks to finalize, the directorate already is supporting space station operations. It also will manage commercial crew and cargo developmental programs; construction of the Orion Multipurpose Crew Vehicle, a spacecraft designed to travel beyond low Earth orbit; development of a new heavy lift rocket, known as the Space Launch System; and other programs within the directorates."America is opening a bold new chapter in human space exploration," NASA Administrator Charles Bolden said in a statement. "By combining the resources of Space Operations and Exploration Systems, and creating the Human Exploration and Operations Mission Directorate, we are recommitting ourselves to American leadership in space for years to come."Associate Administrator Bill Gerstenmaier will head the new organization. He previously served as the associate administrator for Space Operations.